Table 2 Patient and disease characteristics
Item | N | N in % |
|---|---|---|
Total | 358 | 100 |
Gender | ||
 Female | 272 | 77 |
 Male | 83 | 23 |
Age | ||
 18–24 | 15 | 4 |
 25–34 | 42 | 12 |
 35–44 | 31 | 9 |
 45–54 | 64 | 18 |
 55–64 | 99 | 28 |
 65–80 | 105 | 30 |
Education level | ||
 Low (elementary school, primary school, real school or similar, 2-year high school or vocational school, 3–4 year high school) | 105 | 30 |
 Medium (college or university shorter than 3 years) | 89 | 25 |
 High (college or university 3 years or longer) | 162 | 45 |
Occupational status | ||
 Full time employee, part time employee, parental leave/occupational leave | 154 | 43 |
 Work part time since RA, long-term sick leave, sick pension | 79 | 22 |
 Age pensioner/unemployed | 177 | 33 |
 Other | 6 | 2 |
Health literacy | ||
 Sufficient | 197 | 55 |
 Problematic | 134 | 38 |
 Lacking | 24 | 7 |
Numeracy | ||
 High | 28 | 8 |
 Medium | 212 | 60 |
 Low | 113 | 32 |
Disease duration | ||
 1–12 months | 22 | 6 |
 1–5 years | 88 | 25 |
 5–10 years | 67 | 19 |
 More than 10 years | 179 | 50 |
Time till onset of drug effect | ||
 0–3 months | 121 | 34 |
 3–12 months | 87 | 25 |
 1–2 years | 33 | 9 |
 2–5 years | 37 | 11 |
 More than 5 years | 32 | 9 |
 Still not working | 43 | 12 |
Experience with treatment | ||
 First line treatment only (csDMARDs) | 182 | 51 |
 Second line treatment, biologics | 116 | 32 |
 JAK inhibitors | 12 | 3 |
Experience with side effects | ||
 Mild short term | 205 | 57 |
 Appearance | 154 | 43 |
 Psychological | 137 | 38 |
 Severe | 80 | 22 |
 No side effects | 89 | 24 |